U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07911514) titled 'A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234' on Oct. 26.
Brief Summary: This study in healthy volunteers aims to compare blood levels and side effects after administration of different formulations of two test medicines, AZD9550 and AZD6234.
This study will take place at one site in Nottingham, United Kingdom, and will randomize 60 healthy men and women aged 18-55 years living with overweight/obesity.
Study Start Date: Nov. 09
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: AZD9550 solution for injection
AZD9550 solution for inject...